Curation FAME4 YEATS2
3 + 3 = 6 / 18
Genetic evidence
Total: 3
Category | Type | Citation | Score | Details |
|---|---|---|---|---|
Singular Evidence | Probands | 1.5 | One Thai BAFME4 family/proband: long-read sequencing identified an intronic YEATS2 (TTTTA)n expansion with TTTCA insertion; RP-PCR and long-range PCR confirmed expanded alleles in affected family members, with TTTCA absent from unaffected relatives and 1116 Thai controls. | |
Collective Evidence | Segregation | 1.5 | Genome-wide linkage in a Thai autosomal dominant BAFME family with 13 affected members mapped disease to chromosome 3q26.32-q28; D3S1262 had maximum two-point LOD 5.419 at θ=0, refined to a 10 Mb interval between D3S3730 and D3S1580. |
Experimental evidence
Total: 3
Category | Type | Citation | Score | Details |
|---|---|---|---|---|
Function | Biochemical function | 0.5 | Gene-level evidence: pan-neuronal dYEATS2 knockdown in Drosophila reduced dopamine content and lowered tyrosine hydroxylase transcript/protein levels, supporting a role for YEATS2 in dopamine biosynthesis; the human repeat expansion was not directly modeled. | |
Function | Regulatory impact | 0.5 | Gene-level expression evidence: dYEATS2 knockdown altered dopaminergic pathway expression markers, including reduced tyrosine hydroxylase and changes in vMAT/D2R; the study did not directly test regulatory effects of the human intronic TTTTA/TTTCA expansion. | |
Models | Non-human model organism | 2 | Drosophila pan-neuronal dYEATS2 knockdown caused seizure-like behaviours after electric, thermal, and mechanical stress, with locomotor/social/exploratory deficits; L-DOPA improved seizure-like and exploratory phenotypes. This models YEATS2 loss of function, not the human repeat expansion. |